| The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody-and cell-mediated immune responses in mice J Kovacs-Nolan, L Latimer, A Landi, H Jenssen, REW Hancock, ... Vaccine 27 (14), 2055-2064, 2009 | 89* | 2009 |
| High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer A Landi, LA Babiuk, S van Drunen Littel-van den Hurk J Leukoc Biol 82 (4), 849-860, 2007 | 75* | 2007 |
| Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis A Landi, TJ Weismuller, TO Lankisch, DM Santer, DLJ Tyrrell, MP Manns, ... Journal of Interferon & Cytokine Research 34 (3), 204-214, 2014 | 60 | 2014 |
| Dendritic cells matured by a prostaglandin E2-containing cocktail can produce high levels of IL-12p70 and are more mature and Th1-biased than dendritic cells treated with TNF-α … A Landi, LA Babiuk Immunobiology 216 (6), 649-662, 2011 | 47* | 2011 |
| Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome A Landi, D Broadhurst, SD Vernon, DLJ Tyrrell, M Houghton Cytokine 78, 27-36, 2016 | 46 | 2016 |
| Progress towards a hepatitis C virus vaccine L Man John Law, A Landi, WC Magee, D Lorne Tyrrell, M Houghton Emerging microbes & infections 2 (1), 1-7, 2013 | 46 | 2013 |
| DNA prime–protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge R Liang, JV Van den Hurk, A Landi, Z Lawman, D Deregt, H Townsend, ... Journal of General Virology 89 (2), 453-466, 2008 | 45 | 2008 |
| Enhanced activation of memory, but not naive, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis DM Santer, MM Ma, D Hockman, A Landi, DLJ Tyrrell, M Houghton PloS one 8 (6), e68308, 2013 | 44 | 2013 |
| Role of the E2 hypervariable region (HVR1) in the immunogenicity of a recombinant hepatitis C virus vaccine JLM Law, M Logan, J Wong, J Kundu, D Hockman, A Landi, C Chen, ... Journal of Virology 92 (11), e02141-17, 2018 | 35 | 2018 |
| Native folding of a recombinant gpE1/gpE2 heterodimer vaccine antigen from a precursor protein fused with Fc IgG M Logan, J Law, JAJX Wong, D Hockman, A Landi, C Chen, K Crawford, ... Journal of virology 91 (1), e01552-16, 2017 | 34 | 2017 |
| Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes A Landi, J Law, D Hockman, M Logan, K Crawford, C Chen, J Kundu, ... Vaccine 35 (50), 6949-6956, 2017 | 29 | 2017 |
| Indolamine 2, 3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients S Schulz, A Landi, R Garg, JA Wilson, S van Drunen Littel-van den Hurk Clinical & Experimental Immunology 180 (3), 484-498, 2015 | 29 | 2015 |
| Effect of different adjuvants on the longevity and strength of humoral and cellular immune responses to the HCV envelope glycoproteins B Akache, L Deschatelets, BA Harrison, R Dudani, FC Stark, Y Jia, ... Vaccines 7 (4), 204, 2019 | 28 | 2019 |
| No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome I Steffen, DL Tyrrell, E Stein, L Montalvo, TH Lee, Y Zhou, K Lu, ... PloS one 6 (11), e27870, 2011 | 25 | 2011 |
| SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1 JLM Law, M Logan, MA Joyce, A Landi, D Hockman, K Crawford, ... Vaccine 39 (40), 5769-5779, 2021 | 18 | 2021 |
| Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation A Landi, H Yu, LA Babiuk, S van Drunen Littel‐van den Hurk Journal of Viral Hepatitis 18 (10), 700-713, 2011 | 14* | 2011 |
| Investigation of the level of IgG, IgM and IgA antibodies against A60 antigen in tuberculosis patients referred to PHLS, Ahvaz, Iran AD Khosravi, R Torabizadeh, A Landi Pakistan Journal of Meical sciences 21 (4), 465-469, 2005 | 10 | 2005 |
| A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis Y Gindin, C Chung, Z Jiang, JZ Zhou, J Xu, AN Billin, RP Myers, ... Hepatology 73 (3), 1105-1116, 2021 | 6 | 2021 |
| Virological footprint of T-Cell responses in patients with primary biliary cirrhosis M Rahbari, D Sharon, A Landi, M Houghton, A Mason Canadian Journal of Gastroenterology and Hepatology 29, 159A, 2015 | 5 | 2015 |
| The compound (3-{5-[(2, 5-dimethoxyphenyl) amino]-1, 3, 4-thiadiazolidin-2-yl}-5, 8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrPC to PrPSc with … NS Pagadala, TC Bjorndahl, M Joyce, DS Wishart, K Syed, A Landi Bioorganic & Medicinal Chemistry 25 (20), 5875-5888, 2017 | 4 | 2017 |
Michael HoughtonVerified email at ualberta.ca
